Anti-CD20 Therapy Shows No Effect on Disability Progression in MS
THURSDAY, Sept. 26, 2024 (HealthDay News) — For patients with primary progressive multiple...
Read More
Pharmacy
FDA Approves Bimzelx for Three New Indications
THURSDAY, Sept. 26, 2024 (HealthDay News) — The U.S. Food and Drug Administration has...
Read More
FDA Approves Injectable Ocrevus Zunovo for Relapsing, Progressive MS
THURSDAY, Sept. 26, 2024 (HealthDay News) — The U.S. Food and Drug Administration has...
Read More
Childhood Vaccination Coverage Lower for Children Born in 2020, 2021
THURSDAY, Sept. 26, 2024 (HealthDay News) — Children born in 2020 to 2021 had lower coverage...
Read More
Novo Nordisk CEO Grilled by Congress Over Price of Ozempic
WEDNESDAY, Sept. 25, 2024 (HealthDay News) — During a tense hearing before a Senate...
Read More
Semaglutide Beneficial for Hidradenitis Suppurativa in Patients With Obesity
WEDNESDAY, Sept. 25, 2024 (HealthDay News) — For patients with obesity, the addition of...
Read More
Early Adoption of DOAC Dashboard Reduces Off-Label Prescribing
WEDNESDAY, Sept. 25, 2024 (HealthDay News) — Early adoption of the direct oral anticoagulant...
Read More
Semaglutide May Lower Risk for Opioid Overdose in T2DM, Opioid Use Disorder
WEDNESDAY, Sept. 25, 2024 (HealthDay News) — For patients with type 2 diabetes (T2D) and...
Read More
UBE Microdiscectomy Beneficial for Lumbar Disc Herniation
TUESDAY, Sept. 24, 2024 (HealthDay News) — For adults with symptomatic lumbar disc...
Read More
Skeletal Muscle Relaxants Beneficial for Only Certain Conditions
TUESDAY, Sept. 24, 2024 (HealthDay News) — Long-term use of skeletal muscle relaxants (SMRs)...
Read More
14 Percent of U.S. Adults Meet Criteria for Absolute Iron Deficiency
TUESDAY, Sept. 24, 2024 (HealthDay News) — A considerable proportion of U.S. adults has...
Read More
Few U.S. Jails Offer Medications for Opioid Use Disorder
TUESDAY, Sept. 24, 2024 (HealthDay News) — Few U.S. jails offer medications for opioid use...
Read More
Paternal Antiseizure Rx Use at Conception Does Not Pose Risk to Offspring
MONDAY, Sept. 23, 2024 (HealthDay News) — Limited data indicate that paternal exposure to...
Read More
High Response Incidence Seen for Axatilimab in Recurrent, Refractory GVHD
MONDAY, Sept. 23, 2024 (HealthDay News) — For patients with recurrent or refractory...
Read More
Pomalidomide Efficacious in Hereditary Hemorrhagic Telangiectasia
MONDAY, Sept. 23, 2024 (HealthDay News) — For patients with hereditary hemorrhagic...
Read More
Review Compares Drug Interventions for Acute Migraine Treatment
MONDAY, Sept. 23, 2024 (HealthDay News) — All active interventions show superior efficacy to...
Read More
Pembrolizumab + Chemo Beneficial for Early-Stage Triple-Negative Breast Cancer
THURSDAY, Sept. 19, 2024 (HealthDay News) — For patients with early-stage triple-negative...
Read More
Improvement Seen in Vaccine Completion Among Military Children
THURSDAY, Sept. 19, 2024 (HealthDay News) — Among military children, there has been an...
Read More
Cost Has Many Going Around Doctors to Get Weight-Loss Medications
WEDNESDAY, Sept. 18, 2024 (HealthDay News) — Wegovy, Zepbound and other cutting-edge...
Read More
FDA Expands Use of Breast Cancer Drug Kisqali
WEDNESDAY, Sept. 18, 2024 (HealthDay News) — Women with early-stage breast cancer may now...
Read More